Gene Query: DKK3

Dataset Description Geneva Score
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 98.52
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 89.46
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 72.25
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 71.06
RNA-seq of human aneuploid cell lines with Trisomy 21 61.97
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 58.21
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 56.41
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 56.38
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 56.38
Fbxo32 mediated gene expression program underlies EMT and metastasis 55.68
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 53.95
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 52.99
Global analyses of the effect of different cellular contexts on microRNA targeting 51.8
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 51.8
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 50.67
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 50.24
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 50.24
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 48.78
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 47.4
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 47.4
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 47.35
High level DNA repair gene expression in human ES cells 46.67
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 46.19
DJ-1 is dispensable for human stem cell homeostasis 45.6
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 45.46
A role for ZNF598 in post-transcriptional gene regulation 44.84
Evolution of a transcriptional regulator from a transmembrane nucleoporin 44.37
RNA-seq in HepG2 and IMR90 cells 44.37
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 43.17
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 42.96
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 42.54
Transcriptome profiling of Normal and Cancerous Prostate Cells 42.5
G-quadruplex structures mark human regulatory chromatin 41.91
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 41.7
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 41.66
Gene expression analysis of immortalized human liver progenitor-like cells in culture 41.58
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 41.42
A549 cells and MSR-A549 cells 41.42
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 41.26
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 41.05
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 41.02
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 40.82
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 40.65
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 40.65
BAF controls genome accessibility 40.57
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 40.21
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 40.21
RNA-seq of MCF10A cells and CAF 39.43
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 39.26
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 39.26
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 39.07
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 38.89
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 38.19
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 38.16
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 38.12
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 38.12
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 38.07
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 37.97
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 37.97
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 37.95
The landscape of alternative splicing in aggressive prostate cancers 37.7
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 37.42
Transcriptome analysis of H9 hESC derived cerebral organoids 36.94
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 36.5
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 36.49
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 36.44
Identification of the role of polydom in neurofibromas 36.4
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 36.18
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 35.94
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 35.6
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 34.95
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 34.78
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 34.69
TCF7L1 knockdown in pancreatic cancer 34.54
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 33.74
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 33.57
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 33.57
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 33.25
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 33.25
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 33.25
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  32.2
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 32.1
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 32.06
A prostate cancer chromatin interaction map 31.87
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 31.5
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 31.48
Entrectinib Resistance in a Neuroblastoma Xenograft Model 31.11
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 30.36
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 30.22
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 30.18
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 30.17
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 30.15
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 30.15
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 29.96
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 29.96
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 29.75
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 29.75
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 29.51
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 29.17
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 29.17
Modeling Familial Cancer with iPSC Approaches 28.7
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  28.64
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 28.51
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 28.5
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 28.47
RNA-sequencing of human tendon after injury 28.38
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 28.25
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 28.21
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 28.21
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 28.07
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 28.05
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 27.8
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 27.77
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 27.77
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 27.54
Proteomics identifies a marker signature of MAPKi resistance in melanoma 26.43
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 26.39
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 26.32
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 26.29
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 26.04
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 25.97
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 25.74
Transcriptome analyses of human pancreatic islets and pseudoislets 25.63
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 25.49
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 25.49
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 25.42
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 25.42
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 25.15
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 25.02
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 24.98
circRNA-sequencing 24.96
Transcriptional responses of melanoma cells to BRAF inhibition 24.93
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 24.83
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 24.74
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 24.71
Inhibition of TNBC metastasis by Gpx1 24.66
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 24.5
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 24.5
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 24.44
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 24.24
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 24.19
Altering cancer transcriptomes using epigenomic inhibitors 24.07
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 24.07
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 24.02
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 23.95
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 23.89
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 23.76
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 23.76
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 23.7
PNET animal model: new insights (II) 23.62
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 23.62
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 23.51
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 23.5
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 23.47
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 23.35
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 23.18
Differentially expressed vascular development genes for iPSC-ECs from CDI 23.16
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 23.09
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 23.07
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 23.07
Functional role of SLIT2 and ROBO1 in trophoblasts 23.05
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 23.03
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 22.21
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 22.21
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 22.16
Differentiation enhances Zika virus infection in neuronal brain cells 22.08
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 22.08
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 21.83
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 21.77
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 21.47
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 21.34
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 21.31
Examining serotonergic neuron differentiation from human iPSCs 20.99
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 20.96
Transcriptomic and gene ontology profiling of the human corneal cell types 20.8
Oncogenic MYC induces a dependency on the spliceosome in human cancer 20.79
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 20.61
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 20.53
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 20.47
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 20.34
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 20.34
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 20.08
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 20.08
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 19.71
A sister of NANOG regulates genes expressed in pre-implantation human development 19.6
High-efficiency RNA-based reprogramming of human primary fibroblasts 19.49
Generation of trichogenic adipose-derived stem cells by expression of three factors 19.48
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 19.35
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 19.26
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 19.26
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 19.19
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 19.0
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 18.83
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 18.83
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 18.73
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 18.64
RNA-seq analysis of RALD iPSCs after in vitro differentiation 18.47
Genome-wide Analysis of Chromatin Interactions in Human Cells 18.36
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 18.35
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 18.35
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 18.31
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 18.27
Gene expression changes in human melanoma cell lines compared to primary melanocytes 18.26
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 18.13
Transcriptional profiling of microglia; current state of the art and future perspectives 18.13
Alteration of the microRNA network during the progression of Alzheimer’s disease 18.11
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 18.07
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 18.07
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 18.04
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 18.04
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 18.03
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 17.77
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 17.66
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 17.66
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 17.63
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 17.63
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 17.58
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 17.49
RNA sequencing with KSHV infection and enrichment for circular RNAs 17.47
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 17.47
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 17.44
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 17.41
Transcriptomic profile of human embryonic renal corpuscles 17.34
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 17.33
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 17.25
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 17.2
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 17.12
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 17.07
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 17.07
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 16.88
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 16.79
The interplay between SOX4 and SMAD3 in the context of breast cancer 16.73
A transcriptome dataset revealing the molecular features of breast cancer stem cells 16.69
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 16.68
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 16.62
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 16.34
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 16.33
Zika virus infection reprograms global transcription of host cells to allow sustained infection 16.27
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 16.22
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 16.22
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 16.19
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 16.19
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 16.08
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 16.07
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 16.05
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 15.96
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 15.89
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 15.88
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 15.88
Epigenomic landscape during organ formation in human early embryos 15.84
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 15.81
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 15.74
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 15.6
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 15.6
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 15.46
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 15.46
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 15.45
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 15.42
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 15.42
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 15.37
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 15.35
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 15.35
Dynamic reorganization of nuclear architecture during human cardiogenesis 15.26
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 15.26
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 15.18
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 15.04
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 14.83
Next Generation Sequencing of human SMA and healthy control Motor Neurons 14.72
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 14.71
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 14.71
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 14.69
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 14.69
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 14.53
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 14.53
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 14.48
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 14.43
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 14.41
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 14.41
Integrin signaling regulates YAP/TAZ to control skin homeostasis 14.3
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 14.27
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 14.23
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 14.22
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 14.22
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 14.15
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 14.12
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 14.11
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 14.09
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 14.06
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 14.0
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 13.99
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 13.89
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 13.89
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 13.82
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 13.82
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 13.64
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 13.56
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 13.42
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 13.42
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 13.24
Molecular Mechanisms of Endothelial Hyperpermeability 13.17
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 13.13
Widespread regulated alternative splicing of single codons accelerates proteome evolution 12.84
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 12.78
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 12.78
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 12.62
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 12.61
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 12.53
ARID1A and ARID1B loss in HCT116 and TOV21G cells 12.51
BI Human Reference Epigenome Mapping Project 12.4
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 12.3
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 12.25
BMS-470539 on human synovial fibroblasts 12.18
p63 controls the enhancer landscape during keratinocyte differentiation 12.18
CSL 12.16
CSL RNA-Seq on HKC and SCC cell lines 12.16
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 12.06
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 12.02
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 11.98
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 11.96
Endometrial transcriptome and PGR cistrome in cycling fertile women 11.96
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 11.71
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 11.71
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 11.59
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 11.54
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 11.3
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 11.26
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 11.26
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 11.06
Total RNA sequencing of APC mutant and wt colonic organoids 11.05
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 10.91
Gene expression profiling of human and murine in vitro muscle differentiation 10.84
EWS-Fli and LNC regulated genes in comparison to GFP samples 10.7
Gene expression patterns define the hepatocyte-like cells derived by different strategies 10.59
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 10.59
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 10.38
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 10.38
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 10.34
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 10.24
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 10.15
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 10.12
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 10.04
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 9.94
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 9.63
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 9.44
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 9.44
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 9.41
RNA splicing alteration on glioblastoma and normal neural stem cells 9.37
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 9.37
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 9.37
Survival of pancreatic cancer cells lacking KRAS function 9.3
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 9.26
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 9.07
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 9.07
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 8.89
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 8.86
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 8.77
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 8.76
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 8.47
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 8.17
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 8.09
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 8.09
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 8.06
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 8.05
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 8.01
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 7.99
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 7.99
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 7.91
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 7.91
mRNA sequencing of oropharyngeal cancer cell lines 7.84
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 7.8
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 7.71
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 7.57
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 7.49
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 7.49
7.49
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 7.49
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 7.37
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 7.31
Aortic Valve Tissue: Stenosis vs. Sclerosis 7.22
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 7.09
MAIT cell RNA sequencing 7.03
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 6.93
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 6.85
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 6.72
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 6.71
Positively selected enhancer elements endow tumor cells with metastatic competence 6.71
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 6.7
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.66
Differential gene expression of human melanoma cells [RNA-seq] 6.66
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 6.65
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 6.39
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 6.31
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 6.29
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 6.25
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 6.2
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 5.98
RNA seq_PDX2_SHP099 5.88
Metabolism as an early predictor of DPSCs aging 5.83
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 5.75
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 5.54
Genome-wide identification of cancer-specific alternative splicing in circRNA 5.47
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 5.45
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 5.44
The expression profiles of GBC liver metastasis 5.43
circRNA-sequencing 5.33
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 4.99
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 4.93
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 4.93
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 4.91
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 4.84
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 4.84
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 4.82
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 4.82
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 4.7
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 4.62
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 4.62
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 4.62
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 4.6
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 4.6
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 4.44
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 4.43
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 4.43
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 4.42
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 4.37
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.34
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 4.33
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 4.22
Gene expression of thyroid cancer cell lines 4.2
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.94
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 3.93
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 3.93
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 3.9
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 3.81
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 3.81
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 3.76
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.68
Gene expression profiling of papillary thyroid cancer from central and invasive regions 3.56
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 3.45
6mer seed toxicity in tumour suppressive microRNAs 3.39
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 3.13
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.07
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.07
6mer seed toxicity in viral microRNAs 3.03
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 2.92
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.9
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.9
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.88
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 2.81
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 2.75
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 2.6
mRNA differential expression analysis in a human ex vivo model of chronic wounds 2.56
RNA-Seq of Breast and Ovarian Cancer Cell Lines 2.48
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 2.36
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 2.35
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 2.32
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 2.23
Gene expression analysis of human liver progenitor-like cells in culture 2.14
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.13
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 2.03
Effect of from Human Umbilical Vein Endothelial Cells 2.02
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.01
Identification of differentially expressed genes between senescence and senescence bypass cells 1.92
Expression patterns in chronic thromboembolic pulmonary hypertension 1.85
Fibroblasts in cholesteatoma activate osteoclasts. 1.84
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 1.64
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 1.57
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.54
The transcriptome of Kawasaki Disease arteritis 1.42
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 1.31
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 1.2
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 1.17
Transcriptome-wide response to synthetic chromatin protein PcTF 0.99
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.98
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.98
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.98
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.97
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.95
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.9
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 0.87
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.87
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.86
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.81
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.77
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 0.69
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.58
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.52
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.52
Exogenous rescue of KLHL9 in SF210 cell line 0.5
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.43
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.37
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.34
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.33
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.33
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.32
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.31
Dilated cardiomyopathy vs Myocarditis 0.24
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.19
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.19
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.12
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation